You are here

  • Home
  • Archive
  • Volume 10, Issue Suppl 2
  • 937 Post-immunotherapy survivorship in advanced melanoma (aMEL): routine versus symptom-based imaging surveillance, a retrospective review in a large integrated healthcare network, Kaiser Permanente Northern California (KPNC)

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Education and Treatment Management
937 Post-immunotherapy survivorship in advanced melanoma (aMEL): routine versus symptom-based imaging surveillance, a retrospective review in a large integrated healthcare network, Kaiser Permanente Northern California (KPNC)

 

Online download statistics by month:

Online download statistics by month: November 2022 to November 2024

AbstractFullPdf
Nov 2022168014
Dec 20223204
Jan 20232602
Feb 20233404
Mar 20231801
Apr 20231000
May 2023800
Jun 2023601
Jul 2023804
Aug 2023301
Sep 2023201
Oct 20231603
Nov 20232001
Dec 20233607
Jan 20241603
Feb 20241001
Mar 20242402
Apr 20241200
May 20241801
Jun 20241003
Jul 20246403
Aug 20241203
Sep 20241001
Oct 20241002
Nov 20242602
Total599064